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Abstract
The natural product-like carbamide (1) has been identified as a stabilizer of the c-myc G-quadruplex through high-
throughput virtual screening. NMR and molecular modeling experiments revealed a groove-binding mode for 1. The
biological activity of 1 against the c-myc G-quadruplex was confirmed by its ability to inhibit Taq polymerase-mediated DNA
extension and c-myc expression in vitro, demonstrating that 1 is able to control c-myc gene expression at the transcriptional
level presumably through the stabilization of the c-myc promoter G-quadruplex. Furthermore, the interaction between
carbamide analogues and the c-myc G-quadruplex was also investigated by in vitro experiments in order to generate a brief
structure-activity relationship (SAR) for the observed potency of carbamide 1.
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Introduction
G-quadruplexes are non-canonical DNA structures comprised
of planar arrangements of guanine tetrads stabilized by Hoogsteen
hydrogen bonding and monovalent cations. Guanine-rich G-
quadruplex-forming sequences appear frequently in telomeres and
in the promoter regions of growth control genes such as c-myc [1].
Stabilizing the G-quadruplex structure with small molecule ligands
in order to inhibit telomerase activity or repress oncogene
expression has thus emerged as a potential strategy for the
treatment of cancer [2]. The design of G-quadruplex ligands has
traditionally utilized planar aromatic scaffolds that form strong p–
p stacking interactions with the 59 or 39-terminal guanine tetrad of
the quadruplex core [3]. However, targeting the grooves and loops
of the G-quadruplex can potentially offer a higher degree of
selectivity between the different quadruplex topologies due to the
higher structural heterogeneity in the external regions of the G-
quadruplex [4].
The c-myc oncogene encodes a transcription factor that controls
important elements involved in cell cycle regulation, cell growth
and proliferation, and apoptosis. This gene is believed to regulate
15% of all gene expression, and the overexpression of c-myc has
been associated with the progression of malignant tumors [5]. The
nuclear hypersensitivity element III1 (NHE III1) is a guanine-rich
sequence located upstream of the c-myc P1 promoter that controls
80–90% of c-myc transcription [6]. Pu27, a 27-nucleotide (nt) six-
guanine-tract sequence residing within the NHE III1, has been
shown to fold into multiple G-quadruplex structures in solution,
including those resembling the so-called ‘‘propeller-type’’ parallel
intramolecular G-quadruplex [7]. Small molecule ligands that
have been reported to stabilize the c-myc NHE III1 G-quad-
ruplex(es) and inhibit c-myc oncogene transcription include, but are
not limited to, cationic porphyrins [8], quindoline derivatives [9]
and platinum complexes [10]. We have previously identified a c-
myc G-quadruplex stabilizing natural product Fonsecin B, which
was predicted to bind to the c-myc G-quadruplex through end-
stacking at the 39-terminus via its extended aromatic interface, by
high throughput virtual screening [11].
Surprisingly, however, only a few G-quadruplex groove-binders
have been reported to date. Shafer et al. suggested that 3,39-
diethyloxadicarbocyanine (DODC) is able to bind to the groove
region of a dimeric G-quadruplex [12], which was subsequently
validated in a later study [13,14]. In addition, Wilson and co-
workers have demonstrated that certain heterocyclic diamidines
are able to target the groove regions of the human telomeric G-
quadruplex [14]. Meanwhile, Randazzo and co-workers have used
virtual screening and NMR experiments to identify groove-
binding ligands targeting the [d(TGGGGT)]4 G-quadruplex from
a database of 6,000 commercial compounds [15]. Encouraged by
these ideas, we were interested to see if we could apply our
molecular modeling methods to identify new groove-binding
scaffolds targeting the c-myc G-quadruplex from a natural product
and natural product-like database. Natural products are a rich
source of novel chemical scaffolds and their utility in the discovery
of new medicines has been extensively documented [16]. The
synthetic minor groove-binding dye Hoechst 33258 has been
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reported to interact with a AAGGT loop (not present in Pu27) in
a 31-nt c-myc G-quadruplex [17]. The Pu27 parallel intramole-
cular c-myc G-quadruplex contains three propeller loops with an
all-anti arrangement of guanines, except for a 39 snapback syn
guanine at one of the termini. The unique topology of the looping
residues and the snapback loop in the Pu27 c-myc G-quadruplex
gives rise to specific recognition sites in the quadruplex groove
regions which can be exploited by selective small molecule groove-
binders [18]. To our knowledge, no other c-myc G-quadruplex
groove-binder has been reported.
We constructed a model of the intramolecular G-quadruplex
loop isomer of NHE III1 using the X-ray crystal structure of the
intramolecular human telomeric G-quadruplex DNA (PDB code:
1KF1) [7]. This model has previously been utilized to discover c-
myc G-quadruplex stabilizing ligands derived from natural
products [11], quindoline compounds [9] and platinum(II)
Schiff-base complexes [10]. In the present investigation, we
restricted the search area to include only the groove areas in
order to identify novel groove-binding ligands of the c-myc G-
quadruplex. Over 20,000 compounds from a database of natural
product and natural product-like structures were screened in silico.
The continuously flexible ligands were docked to a grid represen-
tation of the receptor and assigned a score reflecting the quality of
the complex according to the ICM method [ICM-Pro 3.6-1d
molecular docking software (Molsoft)] [19]. The highest-scoring
compounds were tested in a preliminary PCR stop assay to assess
their ability to stabilize the c-myc G-quadruplex, and carbamide 1
emerged as the top candidate (Figure 1).
Results and Discussion
To our knowledge, no biological activity or any other properties
of carbamide 1 have been reported in the literature. Structurally, 1
consists of a diphenyl ether unit and a tetracyclic moiety linked
together via an urea functionality. The tetracyclic core contains
the sesquiterpene lactone skeleton found in a-santonin, a common
constituent of Artemisia species that are widely used in traditional
Chinese and Indian herbal remedies for the treatment of
inflammation and other conditions [20]. A biology-oriented
synthesis (BIOS) library containing 1 and close derivatives were
synthesized from a-santonin by Schwarz and co-workers through
a series of modifications, including ring fusion of a 2-thiazole
moiety followed by reaction with various amides, to yield a series
of new carbamides that were active against 5-lipoxygenase,
a mediator in allergy and inflammation [21]. On the other hand,
Sung and co-workers reported a series of carbamide analogues
that can suppress the activity of cyclooxygenase-2 (COX-2) [22].
While these derivatives were all represented in the chemical
database used in our study, 1 displayed the highest activity in vitro.
This suggests that the variable diphenyl ether unit may play
a significant role in enhancing the binding of 1 to the G-
quadruplex.
To verify the mode of binding of compound 1 to the c-myc G-
quadruplex structure, NMR titration experiments were performed
to identify the ligand binding sites. A truncated 24-nt c-myc
sequence Pu24I containing a guanine-to-inosine substitution was
used for this investigation. The triad-containing diagonal loop
(G20–A21–A22–G23) of the c-myc sequence Pu24I connects G19
to G24 and provides a fold-back configuration for G24 while the
double-chain-reversal loops (T7, T16, I10–G11–A12) connect G6
to G8, G15 to G17 and G9 to G13 respectively, thus bridging the
G-tetrad layers [23]. Pu24I has been shown [18] to give a higher
quality NMR spectrum compared to the full-length sequence
Pu27, which forms multiple G-quadruplex topologies in K+
solution. The NMR spectrum of Pu24I in the absence of 1
matches that reported previously [18]. We then titrated compound
1 into a solution of Pu24I (1.0 mM) at ratios of [1]/[Pu24I] = 0–
4.0. Over the course of the titration, we observed appreciable shifts
of 0.02 ppm or higher in the imino proton region for G4, G14,
G17, G18 and G20, suggesting that these residues are most
involved in ligand binding (Figure 2). These shifts were statistically
significant (Figure S1, S2 and Table S1). As these nucleotides are
not collectively involved in the formation of a single tetrad at either
termini, this suggests that 1 binds Pu24I through external
interactions at the grooves or loops of the G-quadruplex.
However, partial stacking interactions with the terminal G-
quartets cannot be ruled out. Also, since G4, G17 and G18 are
located on the opposite side of the G-quadruplex structure
compared to G14 and G20, it is likely that two molecules of 1
are bound to Pu24I at the same time. Furthermore, diminishing
changes in the chemical shift values of the relevant imino protons
were observed as the [1]/[Pu24I] ratio was increased from 2.0 to
4.0. This suggests that the binding stoichiometry of 1 to the c-myc
G-quadruplex is likely to be 2:1. By comparison, end-stackers such
as TMPyP4 have been reported to perturb the guanine residues of
the 59-tetrad (G4, G8, G13 and G17) in the Pu24I NMR spectrum
[18].
To further investigate the mode of binding, we performed
molecular modeling of carbamide 1 with the NHE III1
intramolecular G-quadruplex loop isomer model. The predomi-
nance of the 1:2:1 loop isomer in the c-myc parallel G-quadruplex
structure has been previously demonstrated [24]. As neither NMR
nor X-ray crystal structure for the c-myc NHE III1 1:2:1 loop
isomer was available, we constructed a model from the known,
closely related X-ray crystal structure of the human intramolecular
telomeric G-quadruplex DNA. We used a truncated 18-nt
sequence Pu18 [59-AGGGTGGGGAGGGTGGGG-39] since
the guanine nucleotides G2–G5 in the c-myc sequence [59-
TGGGGAGGGTGGGGAGGGTGGGGAAGG-39] are not in-
volved in G-quartet formation. Our molecular model of the
intramolecular c-myc G-quadruplex consists of three G-quartets
that are associatively formed from four parallel guanine triads
(G2–G4, G6–G8, G11–G13, G16–G18), and three chain-reversal
Figure 1. Chemical structure of carbamide 1.
doi:10.1371/journal.pone.0043278.g001
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loops (T5, G9–A10, T14–G15). The molecular docking results
show that 1 binds strongly to c-myc G-quadruplex DNA with
a binding energy of –47.66 kcal/mol (Figure 3). In the low energy
binding conformation of 1 to Pu18, the molecule is observed to
interact extensively with the groove regions of the G-quadruplex,
contacting the T14–G15 loop as well as the external groove of
G11–G13 (Figure 3, upper panel). The cis-B/C fusion of 1 allows
the A/B face of the molecule to wrap around the top of the G-
quadruplex and form hydrophobic interactions with G11 of the 59-
quartet (Figure 3, lower panel). The snug position of the diphenyl
ether unit in the groove of the c-myc G-quadruplex may explain
the higher activity of 1 compared to related carbamides in the
library that bear other functional groups. The molecular modeling
calculations are consistent with the NMR results, which show
ligand binding to guanine nucleotides from all three G-quartet
levels. Although the topologies of Pu18, Pu24I, and the myriad of
other G-quadruplexes available in the NHE III1 vary to
a significant degree, the artificial stabilization of a particular
quadruplex conformation could, in principle, still exert a useful
pharmacological effect on c-myc transcription in vitro.
To validate our NMR and molecular modeling results, we
performed a PCR stop assay using the Pu27 c-myc G-quadruplex.
We observed a decrease in the intensity of the 43 bp PCR product
upon addition of 1 at 125 mM indicating that 1 is able to stabilize
the c-myc G-quadruplex and block DNA amplification by Taq
polymerase (Figure 4, upper panel). However, 1 had no effect on
the amplification of a non-quadruplex-forming c-myc mutant
sequence. Furthermore, carbamide 1 was selective for the c-myc G-
quadruplex over the human telomeric G-quadruplex (Figure 4,
lower panel). Although the potency of 1 against c-myc was modest,
this could be explained by the fact that 1 is neutral rather than
positively-charged, which reduces the potential coulombic inter-
actions available for binding. Furthermore, groove-binders gener-
ally bind G-quadruplexes less avidly compared to end-stackers.
To investigate the effect of different structural features on the
interaction of the ligands against the c-myc G-quadruplex and to
generate a brief structure-activity relationship (SAR) for carbam-
ide derivatives, we evaluated the c-myc G-quadruplex-stabilizing
activity of a series of analogues of 1 (Figure 5) in the PCR stop
assay. The results showed that inhibition of the PCR product was
only observed at higher concentrations (500 mM) of some of the
analogues (Figure 6). The modest c-myc G-quadruplex stabilizing
activities of analogues 1 and 3 could possibly be attributed to the
presence of phenyl substituents that partly mimic the diphenyl
ether moiety of 1. On the other hand, the presence of an
electronegative chlorine atom on the phenyl group of analogue 2
may have resulted in additional constraints due to enhanced
electrostatic repulsion and weakened Van der Waals interaction,
resulting in lowered activity. Analogues 4 and 5 that lack aromatic
groups attached to the linker were inactive at concentrations of
500 mM. These results further corroborate our molecular model-
ling analysis which suggested that the diphenyl ether moiety in 1
contributes significantly to quadruplex binding and stabilizing
ability.
We next examined whether 1 could inhibit c-myc expression in
a cellular context. To this end, human hepatocarcinoma (HepG2)
cells were incubated with 1 (0–200 mM) for 16 h, and c-myc RNA
levels were quantified using reverse transcriptase PCR (RT-PCR).
Encouragingly, a dose-dependent decrease in c-myc RNA concen-
tration was observed, with an estimated IC50 value of 50 mM
(Figure 7, upper panel). This decrease in c-myc RNA concentration
was expected to be, at least in part, due to the 1-mediated
stabilization of the c-myc NHE III1 G-quadruplex structure(s),
blocking transcription of c-myc by RNA polymerase. The higher
potency of 1 in the cellular assay compared to the cell-free assay
could be possibly attributed to a concentration of the compound
inside the cells or the nucleus of the cells. Alternatively, the
transcription machinery inside cells may be more susceptible to the
aberrant DNA structures induced by 1 compared to the generally
more robust Taq polymerase. Lastly, c-myc RNA levels could be
affected via another mechanism besides that of G-quadruplex
stabilization.
Conclusion
In conclusion, we have identified carbamide 1 as a stabilizer of
c-myc G-quadruplex DNA through structure-based virtual screen-
ing, using a unique model of the c-myc intramolecular parallel-
stranded 1:2:1 loop isomer constructed from the X-ray crystal
structure of the related human telomeric G-quadruplex. The
virtual screening campaign was conducted by restricting the search
region to the external areas of the G-quadruplex, yielding active
candidate 1 that was predicted to bind to the grooves of the c-myc
G-quadruplex as indicated by NMR and molecular modeling
studies. In vitro assays on a series of related compounds generated
a brief structure-activity relationship for carbamide derivatives. To
our knowledge, this is the first application of high-throughput
virtual screening of a natural product database to identify c-myc G-
quadruplex groove-binders. Computer-based hit-to-lead optimi-
zation is currently being carried out in order to generate further
analogues for in vitro testing.
Materials and Methods
Materials
DNA oligomers were obtained from Tech Dragon Limited
(Carlsbad, CA). The sequences for the oligomers were:
Pu27= [59-TGGGGAGGGTGGGGAGGGTGGGGAAGG-
39]
Pu24I = [59-TGAGGGTGGIGAGGGTGGGGAAGG-39]
Pu27mut = [59-TGGGGAGGGTGGAAAGGGTGGG-
GAAGG-39]
HTS= [59-AGGGTTAGGGTTAGGGTTAGGGT-39]
Carbamide 1 and the other tested compounds were purchased
from Analyticon Discovery GmbH (Postdam, Germany) natural
product database. This database, containing over 20,000 natural
product/natural product-like structures, is publicly available and
can be accessed free of charge. Taq DNA polymerase was
purchased from QIAGEN (Valencia, CA). Stock solution of 1
(10 mM) was made in dimethyl sulfoxide (DMSO). Further
dilutions to working concentrations were made with double-
distilled water.
PCR Stop Assay
The polymerase stop assay was performed by using a modified
protocol of the previously reported method [9]. The reactions
(20 mL) were performed in 16PCR buffer, containing each pair of
oligomers (10 mM), deoxynucleotide triphosphate (0.16 mM), Taq
polymerase (2.5 U), and increasing concentrations of the com-
pound 1 (from 0–250 mM). The reaction mixtures were incubated
in a thermocycler under the following cycling conditions: 94uC for
Figure 2. NMR titration of 1 against the c-myc G-quadruplex Pu24I. [1]/[Pu24I] = 0–4.0. [Pu24I] = 1.0 mM (upper panel). Schematic diagram of
the c-myc G-quadruplex with the assigned guanines (lower panel).
doi:10.1371/journal.pone.0043278.g002
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Figure 3. Hypothetical molecular models showing the Side view (upper panel); Top view (lower panel) of the interactions of 1 with
the c-myc G-quadruplex structure. The G-quadruplex is depicted as a ribbon representation (green), while 1 is depicted as a space-filling
representation showing carbon (beige), oxygen (red), nitrogen (blue) and sulfur (yellow) atoms.
doi:10.1371/journal.pone.0043278.g003
c-myc G-Quadruplex DNA Groove-Binder
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3 min followed by 23 cycles of 94uC for 30 s, 58uC for 30 s, and
72uC for 30 s. The amplified products were resolved on 15%
polyacrylamide gel and visualized by ethidium bromide staining.
Molecular Modeling
Molecular docking was performed by using the ICM-Pro 3.6-1d
program (Molsoft) [19,25]. According to the ICM method, the
molecular system was described by using internal coordinates as
variables. Energy calculations were based on the ECEPP/3 force
field with a distance-dependent dielectric constant. The biased
probability Monte Carlo (BPMC) minimization procedure was
used for global energy optimization. The BPMC global-energy-
optimization method consists of 1) a random conformation change
of the free variables according to a predefined continuous
probability distribution; 2) local-energy minimization of analytical
differentiable terms; 3) calculation of the complete energy
including nondifferentiable terms such as entropy and solvation
energy; 4) acceptance or rejection of the total energy based on the
Metropolis criterion and return to step (1). The binding between 1
and DNA was evaluated by binding energy, including grid energy,
continuum electrostatic, and entropy terms. The initial model of
loop isomer was built from the X-ray crystal structures of human
intramolecular telomeric G quadruplex (PDB code: 1KF1) [7],
according to a previously reported procedure [9,10]. Briefly, the
structure of human intramolecular telomeric G quadruplex was
imported into Insight II package (Accelrys Inc., San Diego, CA),
and necessary modifications were carried out including replace-
ments and deletions of bases. Missing loop nucleotides were added
using single-strand B-DNA geometry using the Biopolymer
module. Potassium ions were placed between the G-tetrad planes
to stabilize the tetrad structure. The initial models were then
immersed in a box of TIP3P water molecules, and an appropriate
Figure 4. PCR stop assay with c-myc Pu27 and its mutant Pu27mut (upper panel) and HTS G-quadruplex (lower panel). A decrease in
the PCR amplification product was observed for c-myc at 250 mM of 1 but not for its mutant. No significant inhibition of the HTS PCR product was
observed.
doi:10.1371/journal.pone.0043278.g004
Figure 5. Chemical structures of carbamide 1 analogues (1–5).
doi:10.1371/journal.pone.0043278.g005
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number of sodium ions was added to neutralize the negative
charge of the phosphate backbone. The molecular dynamics
simulations were carried out in NAMD with VMD monitoring the
process. The CHARMM force field parameter was assigned to
every atom, and the Particle Mesh Ewald electrostatics was used to
compute long-range electrostatic interactions. Hydrogen atoms
were added and minimized by 3000 steps of conjugate gradient
minimization. After 4000 steps of conjugate gradient minimiza-
tion, two stages of molecular dynamics simulations were carried
out at 300 K. In the first stage, only the loop area atoms were
allowed to move, and this process involved a 20 ps equilibration
and 100 ps simulations. The second stage involved unrestrained
molecular dynamics simulations with 20 ps equilibration and
100 ps simulations at 300 K. Trajectories were recorded every
0.1 ps, and the most stable structure was extracted and further
refined by 2500 steps of conjugate gradient minimization. In the
docking analysis, the binding site was assigned to the groove
regions of the DNA molecule. The ICM docking was performed to
find the most favorable orientation. The resulting trajectories of
the complex between 1 and G-quadruplex DNA were energy
minimized, and the interaction energies were computed.
1H NMR Titration Experiments
The oligonucleotide Pu24I was annealed in buffer containing
150 mM KCl, 25 mM KH2PO4, 1 mM EDTA, pH 7.0 at 95uC
for 10 min followed by slowly cooling to room temperature. 1H
NMR experiments were performed with a Bruker AV600
spectrometer fitted with a cryoprobe. Typical acquisition condi-
tions for a 1H NMR spectrum were 90u pulse length, 2.0 s
relaxation delay, 32 K data points, 16 ppm spectrum width, 64–
Figure 6. PCR stop assays of the c-myc G-quadruplex with increasing concentrations of carbamide 1 analogues.
doi:10.1371/journal.pone.0043278.g006
Figure 7. RT-PCR results showing dose-dependent decrease in
c-myc transcription (upper panel) after incubation of HepG2
cells with 1 (0–200 mM) or TMPyP4 (50 mM) for 16 h. Equal RNA
loading was confirmed by b-actin (lower panel).
doi:10.1371/journal.pone.0043278.g007
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128 transients, and Pu24I in 90% H2O/10% D2O with 150 mM
KCl, 25 mM KH2PO4, 1 mM EDTA, pH 7.0. Aliquots of a stock
solution of 1 in DMSO-d6 were titrated directly to the DNA
solution inside an NMR tube. Spectra were recorded at 298 K
utilizing a standard jump-return pulse sequence for water
suppression with a relaxation delay of 2.0 s.
Cell culture. Human hepatocarcinoma (HepG2) cells were
maintained in minimum essential medium (MEM) supplemented
with fetal bovine serum (10%), penicillin (100 U mL21), strepto-
mycin (100 mg mL21) at 37uC under a humidified atmosphere
with 5% CO2.
Reverse Transcriptase-polymerase Chain Reaction (RT-
PCR)
HepG2 cells were grown in six-well plates for 24 h. The cells
were treated with the indicated concentrations of 1 for 16 h. Total
RNA was extracted according to the manufacturer’s (Qiagen)
instruction. Reverse transcription was carried out by incubating
RNA (1 mg), random primers (100 ng) and dNTPs (0.5 mM) at
42uC for 5 min, followed by further incubation with 200 units of
SuperScript II reverse transcriptase in 16First-Strand buffer at
42uC for 30 min for reverse transcription and then at 95uC for
3 min to inactivate the enzyme. PCRs (containing cDNA (1 mg),
dNTPs (10 mM), Taq polymerase (2.5 U), 106PCR buffer and
10 mM of each primer) were performed for 22 cycles, consisting of
15 s at 95uC, 30 s at 58uC and 30 s at 72uC in a thermocycler,
and the extension time was increased to 5 min during the last
cycle. The amplified products were resolved on 1.3% agarose gel
and visualized by ethidium bromide staining.
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